Low-Carbohydrate Threshold Protocol
The speaker bases this protocol on two key studies. The first, a 2021 American Journal of Clinical Nutrition trial, used an LPIR score to show a dose-dependent relationship between carb intake and insulin resistance across 60%, 40%, and 20% carb diets — the lower the carbs, the better the insulin sensitivity. The second, a 2022 JAMA study in 150 pre-diabetics, demonstrated that a structured low-carb approach (<40g net carbs for 3 months, then <60g for 3 months) led to significant reductions in HbA1c, fasting glucose, and body weight, while the usual-diet control group saw no change. He stresses this is not a dogmatic ban on carbs but a necessary 'stop gap' to break the cycle of insulin resistance quickly, giving the pancreas and insulin receptors a chance to reset.
Chronic high carbohydrate intake keeps insulin levels constantly elevated, leading to receptor downregulation, lipid accumulation in liver and muscle, and pancreatic beta-cell stress. Drastically reducing carbs lowers the glucose load, decreases insulin secretion, and allows tissue receptors to regain sensitivity. Over time, intramuscular and hepatic fat are mobilized, improving organ-specific insulin signaling.
The speaker says he spent 2 years reversing his own insulin resistance without this structured numeric approach. He would now use this quantifiable threshold method to cut the recovery time dramatically.
The low carb group saw significant reductions in their HBA1C. They saw reductions in their fasting glucose and they ultimately lost body weight and body fat. Whereas the usual diet group saw zero zilch improvement.

